Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anti-MSLN antibody and pharmaceutical composition for cancer treatment comprising same

Anti-MSLN antibody and pharmaceutical composition for cancer treatment comprising same

US Patent 11401343 · Granted Aug 2, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Bispecific antibody specifically binding to GPNMB and CD3, and use thereof2025
Inverter mounting structure2025
Use of anti-FAM19A5 antibodies for treating atherosclerosis2025
Adeno-associated virus (AAV) delivery of anti-FAM19A5 antibodies2025
Fusion protein comprising IDS and use thereof2024
Use of anti-FAM19A5 antibodies for treating fibrosis2024
Antibody library and antibody screening method using same2024
Nano bubble and hydroxyl radical generator (NBHRG) and processing system to deco2024
Use of anti-family with sequence similarity 19, member A5 antibodies for the tre2023
Use of anti-family with sequence similarity 19, member A5 antibodies for the tre2023
Anti-FAM19A5 antibodies and uses thereof2023
Use of anti-FAM19A5 antibodies for treating cancers2023